Trial Profile
A Randomized, Open-label, Two-Treatment, Two-Period, Two-Sequence, Cross-over Study to Evaluate the Pharmacokinetic Properties of SYP-1018 (Voriconazole-loaded PNP) and Voriconazole (Vfend) in Healthy Male Volunteers
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 29 Mar 2016
Price :
$35
*
At a glance
- Drugs Voriconazole (Primary)
- Indications Mycoses
- Focus Pharmacokinetics
- Sponsors Samyang Biopharmaceuticals Corporation
- 25 Mar 2016 Results published in the Drug Design, Development and Therapy
- 22 Apr 2014 New trial record